These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35932682)

  • 1. Charge converting nanostructured lipid carriers containing a cell-penetrating peptide for enhanced cellular uptake.
    Knoll P; Hörmann N; Nguyen Le NM; Wibel R; Gust R; Bernkop-Schnürch A
    J Colloid Interface Sci; 2022 Dec; 628(Pt A):463-475. PubMed ID: 35932682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoarchitectonics of Layer-by-Layer (LbL) coated nanostructured lipid carriers (NLCs) for Enzyme-Triggered charge reversal.
    Akkuş-Dağdeviren ZB; Fürst A; David Friedl J; Tribus M; Bernkop-Schnürch A
    J Colloid Interface Sci; 2023 Jan; 629(Pt A):541-553. PubMed ID: 36088699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine.
    Chen Y; Yuan L; Zhou L; Zhang ZH; Cao W; Wu Q
    Int J Nanomedicine; 2012; 7():4581-91. PubMed ID: 22942642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.
    Beloqui A; Solinís MÁ; des Rieux A; Préat V; Rodríguez-Gascón A
    Int J Pharm; 2014 Jul; 468(1-2):105-11. PubMed ID: 24746410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 6. Zeta Potential Changing Polyphosphate Nanoparticles: A Promising Approach To Overcome the Mucus and Epithelial Barrier.
    Akkus ZB; Nazir I; Jalil A; Tribus M; Bernkop-Schnürch A
    Mol Pharm; 2019 Jun; 16(6):2817-2825. PubMed ID: 31070926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of nanostructured lipid carriers and solid lipid nanoparticles for enhanced cellular uptake.
    Veider F; Akkuş-Dağdeviren ZB; Knoll P; Bernkop-Schnürch A
    Int J Pharm; 2022 Aug; 624():122014. PubMed ID: 35850184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin.
    Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
    Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
    J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-based nanoparticles: Enhanced cellular uptake via surface thiolation.
    Knoll P; Francesco Racaniello G; Laquintana V; Veider F; Saleh A; Seybold A; Denora N; Bernkop-Schnürch A
    Int J Pharm; 2023 Mar; 635():122753. PubMed ID: 36863545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming intestinal barriers by heparanase-responsive charge-converting nanocarriers.
    Veider F; Zöller K; Saleh A; Bernkop-Schnürch A
    Int J Pharm; 2024 Feb; 651():123817. PubMed ID: 38237708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
    Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
    Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphosphate coatings: A promising strategy to overcome the polycation dilemma.
    Le NN; Steinbring C; Le-Vinh B; Jalil A; Matuszczak B; Bernkop-Schnürch A
    J Colloid Interface Sci; 2021 Apr; 587():279-289. PubMed ID: 33360901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide Antibiotic-Polyphosphate Nanoparticles: A Promising Strategy to Overcome the Enzymatic and Mucus Barrier of the Intestine.
    Saleh A; Akkuş-Dağdeviren ZB; Haddadzadegan S; Wibel R; Bernkop-Schnürch A
    Biomacromolecules; 2023 Jun; 24(6):2587-2595. PubMed ID: 37224061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced intestinal absorption of curcumin in Caco-2 cell monolayer using mucoadhesive nanostructured lipid carriers.
    Chanburee S; Tiyaboonchai W
    J Biomed Mater Res B Appl Biomater; 2018 Feb; 106(2):734-741. PubMed ID: 28323388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.